DMPA-SC Self-Injection Feasibility and Acceptability Brief

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s research studies assessing the feasibility and acceptability of self-injection in Uganda and Senegal. For more information, please visit www.path.org/dmpa-sc or email FPoptions@path.org.

Corporate author(s): PATH

Publication date: January 2018

Available materials

  1. English

    1. Self-Injection Feasibility and Acceptability brief - PDF

      Hard copies are not available.

  2. French

    1. Self-Injection Feasibility and Acceptability brief [French] - PDF

      Hard copies are not available.